Showing 34,770 results

Vaginal rings & topical PrEP

WHO continues to support its conditional recommendation for the dapivirine vaginal ring as an additional prevention option for women at substantial risk of HIV

Editor's pick
World Health Organization
13 December 2021
Harm reduction

Overdose prevention centres will save lives, say UK senior doctors

Editor's pick
The Guardian
13 December 2021
Undetectable viral load & treatment as prevention

A Failure to Disseminate Transformative Science — HIV Treatment as Prevention, 10 Years On

Editor's pick
The New England Journal of Medicine (free registration required)
13 December 2021
Drug policy & policing

What next for the Philippines’ war on drugs?

Editor's pick
The Lancet (free registration required)
10 December 2021
PrEP science

Landscape report launched on novel technologies for the prevention of HIV, STIs, and unwanted pregnancy

Editor's pick
Unitaid
10 December 2021
Harm reduction

Charleston’s Syringe Program Can Stay Open Despite Harsh West Virginia Law

Editor's pick
Filter
10 December 2021
Ageing & HIV

Jo Josh on ageing with HIV – GROWS project Video

December 2021
Economic & social inequality

WHO and Global Fund Warn Inequalities Block Progress Towards Ending AIDS, TB and Malaria

Editor's pick
The Global Fund to Fight AIDS, Tuberculosis and Malaria
9 December 2021
Pharmaceutical industry

'Pharma Bro' firm reaches $40M settlement in gouging case

Editor's pick
Associated Press
9 December 2021
HIV in the arts & media

Meet the HIVIPs behind the hit podcast 'Poz Vibe'

Editor's pick
Gay Community News
9 December 2021
Injectable & long-acting HIV treatment

Long-Acting HIV Therapy Hits a Snag

Editor's pick
POZ
9 December 2021
PrEP policies & guidelines

CDC: Tell Everyone About HIV PrEP and Don't 'Grill' Patients

Editor's pick
Medscape (requires free registration)
9 December 2021
Finance & funding

HIV Prevention R&D Funding Drops Again, Even as Major Scientific Advances Require Support

Editor's pick
AVAC
9 December 2021
Injectable & long-acting HIV treatment

The Medicines Patent Pool and the University of Washington sign a licence agreement for an investigational long-acting injectable drug combination candidate for HIV

Editor's pick
Medicines Patent Pool
9 December 2021
Adherence

Digital pill tracks HIV prevention pill adherence with 98 percent accuracy

Editor's pick
European Pharmaceutical Review
9 December 2021
Coronavirus

People living with HIV, regardless of CD4 count or viral load, more likely to experience COVID-19 breakthrough infections

News
8 December 2021

England surpasses global targets for HIV – HIV update, 8 December 2021

December 2021
PrEP programmes & uptake

Practitioners and policies create barriers to PrEP and HIV testing for young people in sub-Saharan Africa

News
8 December 2021
Drug policy & policing

English government announces ‘largest ever’ increase in drug treatment funding

Editor's pick
Drink and Drugs News
7 December 2021
HIV treatment

Doctors Keep Telling Me to Chuck My Longtime HIV Regimen. I’m Not—and Here’s Why

Editor's pick
TheBody
7 December 2021
Pharmaceutical industry

Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multi-pronged R&D strategy

Editor's pick
FierceBiotech
7 December 2021
Malaria

COVID contributed to 69,000 malaria deaths WHO finds, though ‘doomsday scenario’ averted

Editor's pick
UN News
7 December 2021
Treatment outcomes & life expectancy

Susan Cole talks about life expectancy for people living with HIV Video

December 2021
PrEP science

Merck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational, Once-Monthly, Oral Islatravir for Pre-Exposure Prophylaxis (PrEP) of HIV-1 infection

Editor's pick
BusinessWire
7 December 2021